Table 5.
Variables | Exercise group | Dopamine agonists group | Placebo group |
---|---|---|---|
EMCL CSA (cm2) |
|
|
|
Baseline |
13.9±5.1 |
7.6±2.1 |
10.0±5.2 |
6-m post |
11.2±5.8 |
6.8±3.6 |
9.4±2.0 |
Δ Change |
−2.62±5.15 |
−0.79±3.33 |
−0.61±3.92 |
95% CI of Δ Change |
−5.46 to 0.22 |
−3.86 to 2.21 |
−4.23 to 3.01 |
EMCL (%) |
|
|
|
Baseline |
10.9±3.8 |
8.7±3.6 |
8.7±3.9 |
6-m post |
8.2±3.5† |
7.1±2.7 |
8.4±1.5 |
Δ Change |
−2.70±3.90 |
−1.65±3.45 |
−0.21±3.54 |
95% CI of Δ Change |
−4.85 to −0.55 |
−4.83 to 1.53 |
−3.48 to 3.06 |
Muscle CSA (cm2) |
|
|
|
Baseline |
99.5±14.5 |
82.5±22.5 |
98.9±7.3 |
6-m post |
106.8±24.4 |
89.4±24.5 |
95.8±2.0 |
Δ Change |
7.32±16.03 |
6.93±17.66 |
- 3.15±7.87 |
95% CI of Δ Change |
16.18 to −1.54 |
23.22 to −9.39 |
−10.42 to 4.12 |
Muscle (%) |
|
|
|
Baseline |
87.9±3.7 |
85.7±7.2 |
88.1±3.9 |
6-m post |
88.9±4.5 |
88.1±5.9 |
88.2 ±2.2 |
Δ Change |
0.96±5.50 |
2.39±4.89 |
0.07±1.64 |
95% CI of Δ Change |
4.00 to −2.04 |
8.90 to −2.12 |
1.58 to −1.44 |
SAT CSA (cm2) |
|
|
|
Baseline |
142.8±57.8 |
88.7±46.7 |
103.6±28.4 |
6-m post |
143.8±64.8 |
95.5±39.3 |
99.7±14.9 |
Δ Change |
0.98±18.88 |
6.80±19.34 |
−3.95±17.97 |
95% CI of Δ Change | 11.42 to −9.46 | 24.67 to −11.07 | −20.55 to 12.65 |
All data are mean ± SD. Abbreviations: EMCL Extramyocellular lipids (fat infiltration), CSA Cross sectional area, SAT Subcutaneous adipose tissue.
†Significantly different from the respective baseline value.